James Ballance
Keine laufenden Positionen mehr
Profil
James Ballance worked as a Director of Business Development at Aventis Behring from 1999 to 2001.
He was the Vice President of Scientific Affairs at PhaseBio Pharmaceuticals, Inc. in 2013 and 2014.
He was also the Head of Research and Development at Delta Biotechnology Ltd.
Additionally, he worked as the Vice President of Technology Development at BioRexis Pharmaceutical Corp.
from 2003 to 2007.
Dr. Ballance received his undergraduate degree from the University of Wales (Bangor) in 1981 and his doctorate from the University of Bristol in 1984.
Ehemalige bekannte Positionen von James Ballance
Unternehmen | Position | Ende |
---|---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2007 |
Aventis Behring | Corporate Officer/Principal | 01.01.2001 |
PHASEBIO PHARMACEUTICALS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - |
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von James Ballance
University of Wales (Bangor) | Undergraduate Degree |
University of Bristol | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHASEBIO PHARMACEUTICALS, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
BioRexis Pharmaceutical Corp.
BioRexis Pharmaceutical Corp. Pharmaceuticals: MajorHealth Technology BioRexis Pharmaceutical Corp. provides novel protein and peptide drugs with pharmacology and trans-bodies to replace conventional monoclonal antibodies. The company was founded by Christopher P. Prior, Andrew Turner and David R. King in 2002 and is headquartered in Rosemont, PA. | Health Technology |
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Health Technology |
Aventis Behring | Health Technology |